Browse by author
Lookup NU author(s): Dr Guy MacGowanORCiD, Professor John Dark
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 Steunstichting ESOT. Potential heart and lung donors with a history of illicit drugs and/or smoking and alcohol are frequently offered, though there is no clear guidance on when it is safe to use these organs. A review of the literature on effects of drugs, alcohol and smoking on donor outcomes, and the effects of these on the intact heart and lung was undertaken. There has been a marked increase in deaths from opioid abuse in many developed countries, though recent evidence suggests that outcomes after cardiothoracic transplantation are equivalent to nonopioid donor causes of death. For donor smoking, there is an increased risk with lung transplantation; however, that risk is less when compared to further waiting on the transplant list for a nonsmoking alternative. Heavy alcohol consumption does not adversely affect heart transplantation, and there is no clear evidence of adverse outcomes after lung transplantation. There are no overall effects of cannabis or cocaine on survival after heart or lung transplantation. In all these cases, careful donor assessment can establish if a particular organ can be used. In most cases, use of drugs requires careful assessment, but is not in of itself a contraindication to cardiothoracic transplantation.
Author(s): MacGowan GA, Dark JH, Corris PA, Nair AR
Publication type: Review
Publication status: Published
Journal: Transplant International
Year: 2019
Volume: 32
Issue: 10
Pages: 1019-1027
Print publication date: 01/10/2019
Online publication date: 06/06/2019
Acceptance date: 31/05/2019
ISSN (print): 0934-0874
ISSN (electronic): 1432-2277
Publisher: Blackwell Publishing Ltd
URL: https://doi.org/10.1111/tri.13468
DOI: 10.1111/tri.13468
PubMed id: 31172575
